Top wikifolio Goldener Sommervogel nachTyler fits4u +30,2 % seit Beginn +28,5 % 1 Jahr TOP WIKIFOLIO TRADE Kauf 15.11.2023 um 20:45 ISHSIV-E.MSCI USA VAL.FA. IE00BD1F4M44 Kurs (EUR) 7,775 19,0 % Letzte Aktivität Medizin-Revolution One U.S. biotech company nearing a significant milestone in Alzheimer's treatment is Annovis Bio. The company is developing a drug called Buntanetap (formerly Posiphen), which targets several neurotoxic proteins involved in Alzheimer's and other neurodegenerative diseases. It aims to improve brain function by enhancing synaptic transmission and reducing inflammation. Results from Phase 2/3 clinical trials are expected soon, potentially marking a breakthrough in treating Alzheimer's( https://www.biomedwire.com/annovis-bio-inc-nyse-anvs-ceo-discusses-findings-of-buntanetap-phase-2-3-alzheimers-study-on-the-bell2bell-podcast/ ).
Medizin-Revolution One U.S. biotech company nearing a significant milestone in Alzheimer's treatment is Annovis Bio. The company is developing a drug called Buntanetap (formerly Posiphen), which targets several neurotoxic proteins involved in Alzheimer's and other neurodegenerative diseases. It aims to improve brain function by enhancing synaptic transmission and reducing inflammation. Results from Phase 2/3 clinical trials are expected soon, potentially marking a breakthrough in treating Alzheimer's( https://www.biomedwire.com/annovis-bio-inc-nyse-anvs-ceo-discusses-findings-of-buntanetap-phase-2-3-alzheimers-study-on-the-bell2bell-podcast/ ).
